Shop in your local currency and language

Choose another country or region to see specific content for your location and shop online.

United Kingdom
Bioprocess filtration

Scalability of Cadence™ inline concentrator modules for bovine IgG processing

Oct 8, 2026

Introduction

Single-pass tangential flow filtration (SPTFF) technology has changed bioprocessing, through process productivity, flexibility and yield improvements and enabling continuous bioprocessing. SPTFF utilizes a staged flow path design to achieve significantly higher concentration factors than a conventional TFF system in one pump pass (1,2). The single pump pass minimizes shear exposure and eliminates foaming/ mixing concerns. Additionally, pump and tubing sizes are reduced for increased cost savings. System hold-up volumes are also reduced to maximize product recovery with minimal dilution, while expensive hold tanks and large system footprints, characteristic of a conventional TFF system, are eliminated.

Our Cadence inline concentrator (ILC) module is an extension of the SPTFF product line. The Cadence ILC module is a holderless SPTFF unit with a built-in restrictor that is designed to achieve concentration factors of 2 to 4× (or higher). It can be placed virtually anywhere within a given bioprocess to enable inline volume reduction and concentration.

The ILC module requires only a feed pressure source (i.e., pump or pressure vessel) and feed pressure measurement instrument, and an optional flow meter further reducing system requirements (Fig 1). Its reduced system footprint eases facility fit concerns where manufacturing floor space is at a premium.

Fig 1. Cadence inline concentrator setup for testing the concentration of bovine IgG concentration with Delta 10 kDa and 30 kDa membranes.

A few of the potential applications of the Cadence ILC module include: Inline volume reduction, concentration prior to capture step, concentration in between chromatography steps, and replacement of an existing conventional TFF concentration step.

Table 1 shows the eight Cadence ILC modules that are currently available. The ILC modules are available in four format sizes (T01, T02, T12, and T06), which correspond to membrane areas ranging from 0.065 to 3.5 m2. They are available with Delta membrane (regenerated cellulose) in both 10 and 30 kDa molecular weight cutoffs (MWCOs).

Table 1. Available Cadence inline concentrator modules

Membrane Format size Membrane area (m2)
Delta 10 kDa T01
T02
T12
T06
0.065
0.13
0.7
3.5
Delta 30 kDa T01
T02
T12
T06
0.065
0.13
0.7
3.5

It is important that the modules are scalable so that you are able to model their process at lab scale and directly scale-up to process or manufacturing scales. Parameters such as fluxes and concentration factors need to be scalable within an acceptable range, as they are important determinants of processing times, membrane area, and tank sizes required for the scaled-up process.

The main objective of this study was to evaluate the scalability of the performance between commercially available ILC formats and cutoffs over a wide range of processing conditions.

Materials and methods

We tested the smallest (T01, 0.065 m2) and largest (T06, 3.5 m2) ILC modules for scalability with both Delta 10 kDa and 30 kDa membrane. Prior to processing with protein, we set up the system and preconditioned the ILC module.

The holderless design of the ILC module greatly simplified the system set up by allowing for a “plug and play” installation. After sanitizing, flushing, and buffer conditioning the module, processing was carried out with 2 to 10 g/L of polyclonal bovine IgG feedstocks (Lee Biosciences) in PBS buffer. Although the ILC module can potentially be positioned at several locations within a given bioprocess, this concentration range was chosen to represent most case studies where the Cadence ILC module would typically be implemented between primary clarification and final concentration steps.

We tested ILC modules with 10 and 30 kDa membranes over a feed pressure range of 20 to 60 psig to generate performance maps, consisting of volumetric concentration factors (VCF) and respective fluxes (i.e., feed, retentate, permeate) for the 2, 5, and 10 g/L polyclonal bovine IgG feedstocks formulated in PBS buffer. Process information was captured at each setpoint starting from high-to-low throughput run conditions to minimize hysteresis due to concentration polarization (i.e., high-to-low PFEED). Also, multiple data points were taken at each setpoint to verify steady-state and process stability with subsequent sampling to confirm and quantitate the performance. Note that the performance maps were generated in total recirculation mode to conserve solution. In a typical application, the target molecule is processed in single pass, as soon as the target test conditions are finalized.

Feed concentrations and respective feed volumes per ILC module utilized for the scalability study are summarized in Table 2.

Table 2. Materials and feed conditions

Feed concentration Feed volume, T01 module (0.065 m2) T06 (3.5 m2)
2 g/L 5 L 100 L
5 g/L 2 L 40 L
10 g/L 1 L 20 L

The scalability metrics we evaluated in this study were feed flux (L/m2/h), retentate flux (L/m2/h), and VCF with a criterion of 15% that is set to elucidate the performance dissimilarities between the smallest and largest ILC modules.

Results and discussion

The major trends between feed pressure, feed flux, and VCF coupled with the performance benchmark between ILC modules with Delta 10 and 30 kDa membranes (T06, 3.5 m2) is given for the 5 g/L IgG processing case in Figure 2.

Compared to the ILC Delta 10 kDa modules, the Delta 30 kDa modules exhibited higher feed and permeate fluxes, and thus wider range of VCFs (i.e, ~ 15%), due to relative differences in pore size distributions and membrane permeability. As captured in Figure 2, with the decreasing feed pressure and subsequently the feed flux, the feed solution resides longer in the module, allowing for a larger percentage of the flow to permeate and higher concentration factors to be achieved. Therefore, the trade-off between the operating fluxes (processing time) and the achievable VCF ranges (volume reduction), as well as membrane cutoffs, is of great importance to optimize target bioprocessing conditions.

Fig 2. Cadence ILC performance map and benchmark for Delta 10 and 30 kDa T06 (3.5 m2) modules tested with 5 g/L IgG in PBS.

Figure 3 shows the resulting flux and VCF ranges for the Delta 10 kDa and Delta 30 kDa, T01 (0.065 m2) and T06 (3.5 m2) modules, over the feed concentration and operational feed pressure range of 2 to 10 g/L IgG in PBS and 20 to 60 psig, respectively. Both the fluxes and the VCFs for the T01 and T06 modules were similar and within the scalability target of 15% over the entire feed pressure and feed concentration ranges tested.

Fig 3. ILC (A) Delta 10 kDa and (B) Delta 30 kDa scalability for T01 (0.065 m2) and T06 (3.5 m2) modules during processing with 2, 5, and 10 g/L bovine IgG in PBS over the feed pressure operational window of 20 to 60 psig.

Note that the feed flux is a critical determinant for scalability because it regulates processing time, which in turn dictates the membrane area required for a given bioprocess volume.

Similarly, the scalability of VCFs is critical to appropriately determine the required tank sizes for product pooling and/or quantitate the variants in inlet conditions, if ILC outlet is coupled with another unit operation. In addition to robustness of the performance between the process development (PD), pilot-, and manufacturing-scale operations, the volume reduction with ILC will further result in the downsizing of respective downstream unit operations, enabling further cost savings and footprint reduction.

Note that the slight differences in module performance–shown in Figure 3A and B–were attributed to:

  • Minor variations in process temperatures and feed concentrations.
  • Differences in mass and/or volumetric loadings (g/m2 and/or L/m2 IgG feed) between T01 and T06 runs.
  • Feed channel pressure drop of the individual cassettes used to build the respective modules.

Nevertheless, scalability of the process fluxes and VCFs is confirmed by the good agreement between the smallest and largest available ILC modules tested over the entire pressure (20 to 60 psig) and concentration (2 to 10 g/L) range.

The scalable performance of the ILC modules will allow process developers to perform benchmarking runs with PD-scale ILC modules, while being able to gauge the performance of the scaled-up process without further qualification and/or validation runs at pilot and/or manufacturing scales, thus minimizing expensive feedstock needs and saving valuable development time and efforts. You will be able to confidently scale up the ILC fluxes and VCFs to calculate tank sizes, processing times, and membrane areas required for their scaled-up process. For example, the batch processing capacity of ILC Delta 10 and 30 kDa modules is calculated for all the commercially available format sizes, as shown in Figure 4. The case study assumes an 8 h processing window for concentrating a 5 g/L batch by 2.5- to 3-fold when processed at a feed pressure of 60 psig. As high inlet pressures resulting in high feed fluxes, representing the highest throughput case, data shown in Figure 4 suggests that the 3.5 m2 ILC modules can process 3000 to 4000 L batches during the specified target processing time. Similar calculations can be performed to evaluate the impact of other process variables such as membrane area and tank size.

Fig 4. ILC Delta 10 and 30 kDa batch processing capacity at CFEED = 5 g/L and PFEED = 60 psig within an 8 h window for all available cadence ILC module format sizes.

Conclusions

  • Cadence ILC modules provide 2 to 4× (or greater) single-pass concentration for inline volume reduction.
  • Consistent performance was demonstrated across 10 kDa and 30 kDa membranes and across development to manufacturing scales.
  • The smallest (T01, 0.065 m2) and largest (T06 3.5 m2) modules met the 15% scalability criterion for over the entire pressure.
  • Results support accurate scale-up of processing times, membrane area, and tank capacities for bioprocessing applications.
References

  • Casey C, Gallos T, Alekseev Y, Ayturk E, and Pearl, S. Protein concentration with single-pass tangential flow filtration. J Membr Sci. 2011;384(1-2):82-88. doi.org/10.1016/j.memsci.2011.09.004.
  • Dizon-Maspat J, Bourret J, D'Agostini A, Li F. Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production. Biotechnol Bioeng. 2012 Apr;109(4):962-70. doi: 10.1002/bit.24377.


CY62059

Discover the range of Cadence inline concentrator modules
Simplify your processes, increase capacity, and reduce costs with preassembled, single-pass TFF Cadence ILC modules

Did you find what you were looking for?